News

The agreement is said to be a strategic milestone for both companies, strengthening Sunquest’s mission to increase international market share and HCS’s commitment to bring healthcare technology to

The company is seeking approval for Bepreve as an eye drop treatment for ocular itching associated with allergic conjunctivitis. Ista says that Bepreve is a non-sedating, highly selective

MD Anderson is conducting a clinical trial to explore a cord blood expansion technology called ‘Co-culture’. Cord blood is a valuable, non-controversial source of stem cells with effect

This international, multicenter, open-label clinical trial is sponsored by Merck & Co and is part of the Vantage program. The trial will enroll 142 patients from more than

Proceeds from the financing will be used to advance multiple transient receptor potential (TRP) ion channel drug programs, with the most advanced program moving toward clinical trials in

The agreements enable global travelers covered by HTH’s international health insurance programs to arrange convenient appointments for diagnostic and treatment services and to have the clinics bill HTH

In December 2007, GSK and Galapagos initiated a program to discover and develop novel anti-infective drug candidates for GSK’s Infectious Diseases Centre of Excellence in Drug Discovery (ID

deCODEme Cardio detects genetic risk factors for heart attack, stroke and atrial fibrillation, peripheral artery disease (PAD) and several other conditions. deCODEme Cancer measures genetic risk factors for

RiaSTAP is not indicated to treat dysfibrinogenemia. Approval was based on a pivotal Phase II prospective, open-label pharmacokinetic (PK) and safety study using maximum clot firmness (MCF) as